RxDoctor Payments Data

Cheryl Krasner

Physician Assistant · Brooklyn, NYNPI 1679651657

Payments from drug & device makers

$4,695in general payments, 2019–2025

Across 185 payments — averaging $25.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • Novartis$784
  • Novo Nordisk$556
  • Merck$533
  • E.r. Squibb & Sons, L.L.C.$397
  • Johnson & Johnson$372
  • plus $827 from 12 others

What the payments were for

  • Food & beverage$4,695100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,695 in reported general payments places this provider in the 90th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban199$157,185
FarxigaDapagliflozin Propanediol49$56,472
XareltoRivaroxaban36$43,091
JardianceEmpagliflozin45$42,297
EntrestoSacubitril/Valsartan32$34,650
BrilintaTicagrelor64$31,641
OzempicSemaglutide16$20,782
MultaqDronedarone Hcl18$20,246
JanuviaSitagliptin Phosphate27$18,214
VerquvoVericiguat15$16,169
MounjaroTirzepatide14$13,890
LokelmaSodium Zirconium Cyclosilicate15$11,695
Ranolazine ErRanolazine50$3,586
Metoprolol Succinate248$3,021
Losartan Potassium279$1,887

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$82$157,185199 claims
AstraZenecaFarxiga, Brilinta, Lokelma$1,225$99,808128 claims
Johnson & JohnsonXarelto$372$43,09136 claims
Boehringer IngelheimJardiance$168$42,29745 claims
NovartisEntresto$784$34,65032 claims
MerckJanuvia, Verquvo$533$34,38342 claims
Novo NordiskOzempic$556$20,78216 claims
Sanofi-aventis U.S. LLCMultaq$154$20,24618 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 11,358 physician assistant providers in New York.

Other physician assistant in Brooklyn

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →